Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials
- PMID: 25005849
- DOI: 10.1016/j.diabres.2014.06.009
Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials
Abstract
We conducted a meta-analysis to compare the efficacy and safety of repaglinide plus metformin with metformin alone on type 2 diabetes. Twenty-two studies were included in this meta-analysis. Results showed combination therapy was safe and could gain better outcomes in glycemic control. Well-designed studies are required to confirm this conclusion.
Keywords: Combination therapy; Meta-analysis; Metformin; Repaglinide; Type 2 diabetes mellitus.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Comment in
-
Comments on "Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials".Diabetes Res Clin Pract. 2015 Apr;108(1):e1-2. doi: 10.1016/j.diabres.2015.02.004. Epub 2015 Feb 21. Diabetes Res Clin Pract. 2015. PMID: 25747159 No abstract available.
Similar articles
-
Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy.Expert Opin Pharmacother. 2011 Dec;12(18):2791-9. doi: 10.1517/14656566.2011.602341. Epub 2011 Jul 22. Expert Opin Pharmacother. 2011. PMID: 21780853 Clinical Trial.
-
Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.Diabetes Care. 2003 Jul;26(7):2063-8. doi: 10.2337/diacare.26.7.2063. Diabetes Care. 2003. PMID: 12832314 Clinical Trial.
-
Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China.J Diabetes Res. 2014;2014:294017. doi: 10.1155/2014/294017. Epub 2014 Mar 4. J Diabetes Res. 2014. PMID: 24772445 Free PMC article. Clinical Trial.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
Combination therapy in type 2 diabetes: the role of repaglinide.J Assoc Physicians India. 2001 Jan 25;49 Spec No:62-8. J Assoc Physicians India. 2001. PMID: 11235608 Review. No abstract available.
Cited by
-
Drug Therapies for Diabetes.Int J Mol Sci. 2023 Dec 5;24(24):17147. doi: 10.3390/ijms242417147. Int J Mol Sci. 2023. PMID: 38138975 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical